Independent
Tenure on this board
8.7 yrs
Also a director at
Summit Therapeutics Inc (SMMT)
Meeting calendar
PLSE · Annual meeting · Thursday, June 11, 2026
Pulse Biosciences Inc
7 nominees · 3 ballot items.
Stockholders will vote to elect seven directors to the Board, to ratify Deloitte & Touche LLP as the company’s independent registered public accounting firm for 2026, and to transact any other business properly brought before the meeting.
Market cap
$1.9B
1Y TSR
+75.3%
Board grade
B-
Record date
Apr 28, 2026
Filing
DEF 14A
Meeting concluded · Jun 11, 2026
Follow how the vote landed and what changed on Pulse Biosciences Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
Proposals
On the ballot3
- 1
Election of Directors
ManagementBoard: FORElect seven directors (Robert W. Duggan, Paul A. LaViolette, Maria Sainz, Manmeet S. Soni, Darrin R. Uecker, Richard A. van den Broek, and Mahkam Zanganeh) to serve until the 2027 annual meeting and until their successors are elected and qualified.
- 2
Ratification of the Appointment of Independent Registered Public Accounting Firm
ManagementBoard: FORRatify the appointment of Deloitte & Touche LLP as Pulse Biosciences’ independent registered public accounting firm for the fiscal year ending December 31, 2026.
- 3
Other Business
ManagementTransact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof; proxies give discretionary authority to vote on such matters if presented.
Director elections
Nominees on the ballot7
Not independent
Tenure on this board
1.9 yrs
Also a director at
Edwards Lifesciences Corp (EW)
Independent
Tenure on this board
0.5 yrs
Also a director at
Hyperfine Inc (HYPR)
Independent
Tenure on this board
8.7 yrs
Also a director at
Summit Therapeutics Inc (SMMT)
Not independent
Tenure on this board
10.9 yrs
Independent
Tenure on this board
5.9 yrs
Also a director at
Corvus Pharmaceuticals Inc (CRVS)
Independent
Tenure on this board
9.4 yrs
Also a director at
Summit Therapeutics Inc (SMMT)
Ownership
Latest 13F quarterTop institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | BANK OF AMERICA CORP /DE/ | 1.3% | 866,061 | $19M |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 1.2% | 815,852 | $18M |
| 3 | Portolan Capital Management, LLC | 1.1% | 733,372 | $16M |
| 4 | BlackRock, Inc. | 1.0% | 683,017 | $15M |
| 5 | BlackRock, Inc. | 0.7% | 493,117 | $11M |
| 6 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 0.7% | 462,899 | $10M |
| 7 | STATE STREET CORP | 0.7% | 456,927 | $10M |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 0.6% | 428,167 | $9M |
| 9 | BALYASNY ASSET MANAGEMENT L.P. | 0.4% | 265,164 | $6M |
| 10 | GRIFFIN ASSET MANAGEMENT, INC. | 0.3% | 225,177 | $5M |
Peers
Nearest market capOther Healthcare sector meetings6
Upcoming shareholder meetings at Pulse Biosciences Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Trulieve Cannabis CorpTRLV
Special meeting·Aug 5, 2026·$1.6B
Anaptysbio IncANAB
Annual meeting·Aug 11, 2026·$1.6B
Prestige Consumer Healthcare IncPBH
Annual meeting·Aug 4, 2026·$2.4B
Avanos Medical IncAVNS
Special meeting·Jul 22, 2026·$1.2B
Aura Biosciences IncAURA
Special meeting·Aug 5, 2026·$712M
Indaptus Therapeutics IncINDP
Annual meeting·Aug 10, 2026·$287M
Reference
Frequently asked questions
- When is the Pulse Biosciences Inc 2026 annual meeting?
- Pulse Biosciences Inc (PLSE) holds its 2026 annual shareholder meeting on Thursday, June 11, 2026.
- What is the record date for the Pulse Biosciences Inc 2026 meeting?
- The record date for the Pulse Biosciences Inc 2026 meeting is Tuesday, April 28, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Pulse Biosciences Inc's 2026 meeting?
- The board is presenting 7 director nominees at the Pulse Biosciences Inc 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Pulse Biosciences Inc 2026 meeting?
- Shareholders will vote on 3 proposals at the Pulse Biosciences Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.